Jinhe Biotechnology CO., LTD. (SHE:002688)
China · Delayed Price · Currency is CNY 6.02
0.00 (0.00%)
Apr 30, 2026, 3:04 PM CST
SHE:002688 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -10.98 | 100.2 | 86.46 | 75.62 | 93.99 |
Depreciation & Amortization | 238.94 | 193.61 | 179.29 | 155.89 | 132.08 |
Other Amortization | 5.99 | 4.97 | 1.66 | 2.15 | 2.04 |
Loss (Gain) From Sale of Assets | 2.73 | -0.19 | 0.36 | 0.25 | -1.57 |
Asset Writedown & Restructuring Costs | 192.83 | 40.87 | 6.56 | 8.2 | 12.33 |
Loss (Gain) From Sale of Investments | 2.63 | 1.27 | -0.15 | 3.94 | - |
Provision & Write-off of Bad Debts | - | 13.99 | 6.31 | 1.53 | 1.88 |
Other Operating Activities | 95.71 | 124.58 | 80.64 | 94.85 | 95 |
Change in Accounts Receivable | 0.81 | -26.29 | -183.89 | -152.49 | -138.64 |
Change in Inventory | -17.69 | 15.15 | 11.51 | -105.57 | -135.58 |
Change in Accounts Payable | -47.36 | 37.08 | -0.52 | 37.42 | 89.13 |
Change in Other Net Operating Assets | -11.14 | 18.24 | 3.84 | - | -0.09 |
Operating Cash Flow | 468.92 | 498.42 | 198.77 | 124.47 | 152.98 |
Operating Cash Flow Growth | -5.92% | 150.76% | 59.69% | -18.63% | -40.72% |
Capital Expenditures | -320.28 | -362.24 | -457.22 | -402.16 | -383.72 |
Sale of Property, Plant & Equipment | 1.33 | 5.68 | 0.01 | 0.06 | 5.38 |
Cash Acquisitions | - | - | -60.88 | - | -19.24 |
Divestitures | - | 0.89 | - | 19.5 | - |
Investment in Securities | - | -15.51 | -20 | -4.2 | -0.1 |
Other Investing Activities | 4.35 | -0.29 | 3.9 | - | - |
Investing Cash Flow | -314.6 | -371.46 | -534.19 | -386.8 | -397.99 |
Short-Term Debt Issued | - | - | - | 7 | - |
Long-Term Debt Issued | 1,417 | 2,049 | 2,033 | 1,601 | 1,240 |
Total Debt Issued | 1,417 | 2,049 | 2,033 | 1,608 | 1,240 |
Short-Term Debt Repaid | - | - | - | -7 | - |
Long-Term Debt Repaid | -1,426 | -1,866 | -1,440 | -995.53 | -1,574 |
Total Debt Repaid | -1,426 | -1,866 | -1,440 | -1,003 | -1,574 |
Net Debt Issued (Repaid) | -8.9 | 183.08 | 592.77 | 605.86 | -334.09 |
Issuance of Common Stock | 2.35 | - | 55.7 | - | 803.48 |
Repurchase of Common Stock | - | -72.05 | - | -131.89 | - |
Common Dividends Paid | -147.85 | -160.96 | -148.69 | -40.55 | -104.33 |
Other Financing Activities | 30.87 | 10.05 | -86.72 | -282.99 | 83.65 |
Financing Cash Flow | -123.52 | -39.89 | 413.05 | 150.43 | 448.7 |
Foreign Exchange Rate Adjustments | -4.07 | 3.65 | 9.07 | 21.61 | -2.16 |
Net Cash Flow | 26.73 | 90.72 | 86.7 | -90.28 | 201.54 |
Free Cash Flow | 148.64 | 136.18 | -258.45 | -277.69 | -230.74 |
Free Cash Flow Growth | 9.15% | - | - | - | - |
Free Cash Flow Margin | 5.17% | 5.75% | -11.89% | -13.08% | -11.10% |
Free Cash Flow Per Share | 0.19 | 0.18 | -0.33 | -0.36 | -0.33 |
Cash Income Tax Paid | 58.14 | -13.64 | -14.64 | 5.16 | 13.16 |
Levered Free Cash Flow | 43.45 | 28.67 | -274.92 | -182.28 | -294.44 |
Unlevered Free Cash Flow | 43.45 | 78.88 | -237.41 | -159.53 | -261.73 |
Change in Working Capital | -58.92 | 19.12 | -162.36 | -217.96 | -182.77 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.